Info
Significant Ownership

Significant Ownership of Baselake Partners, LP

Signature - Title: /s/ David Paolella - David Paolella, Managing Member of Baselake Management, LLC, its investment manager
Location: Troy, MI
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Baselake Partners, LP.

Notify me when Baselake Partners, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Baselake Partners, LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SYBX	Synlogic, Inc.	Common Stock, par value $0.001 per share	9.7%	$1,265,400		1,140,000		Baselake Partners, LP	20 Jan 2026
NEUP	Neuphoria Therapeutics Inc.	Common Stock, $0.00001 par value per share	4.1%	$862,110		222,222	0%	Baselake Partners, LP	31 Dec 2025
ATHA	LeonaBio, Inc. f.k.a. Athira Pharma, Inc.	Common Stock, $0.0001 par value per share	1.9%	$573,723	-$921,208	75,789	-62%	Baselake Partners, LP	31 Dec 2025
GBIO	Generation Bio Co.	Common Stock, $0.0001 Par Value	0%	$0	-$1,918,000	0	-100%	Baselake Partners, LP	09 Feb 2026

Schedules 13D/G Reported by Baselake Partners, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.